Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement (THR)

January 24, 2024 updated by: Zheng Guo, Second Hospital of Shanxi Medical University

Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacements During Past 5 Years :A Retrospective Analysis

The is a retrospective analysis to study the characteristics of elderly patients treated with total hip replacements during past 5 years．

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Patients underwent total hip replacement due to removal of the hip caused by retrogressive lesions, is conducive to the improvement of hip function .But at the same time,the complications from patients accepted total hip replacement surgery will directly or indirectly affect the prognosis of the patients, resulting in patients with delayed recovery and increase the hospitalization time and cost. Serious complications can lead to patients deaths during perioperative period. This study was designed to provide a retrospective analysis of postoperative recovery, quality of life, and complications in patients undergoing hip replacement over the past five years, providing data for clinical studies.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • China
    • Shanxi
      • Taiyuan, Shanxi, China, 030001
        • Recruiting
        • Zheng Guo
        • Contact:
        • Contact:
        • Principal Investigator:
          • Zheng Guo, MB, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

From January 2012 to July 30，2017，approximately 1500 cases of primary hip replacement in this study，including male ，female and bilateral replacements．

Description

Inclusion Criteria:

  1. ASA Ⅱ-Ⅲ,elective operation patients，
  2. NO other severe complication history

Exclusion Criteria:

  1. Having severe comorbidity
  2. not for the first time of joint replacement
  3. Suffered from neurologic disorder or impaired mental state

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life during 5 years after surgery
Time Frame: 5 years
evaluate the quality of life after surgery by WHO QOL-BREF scale with interview ，WHO QOL-BREF scale includes five aspects: physical, psychological, social, environmental, integrated, divided into five levels
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of postoperative complications
Time Frame: from 7 days to 1 year
Participants will be followed for the incidence of postoperative complications
from 7 days to 1 year
Mortality during 5 years after surgery
Time Frame: during 5 years
Participants will be followed for Survival rate during 5 years after surgery
during 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Second Hospital of Shanxi Medical University

Investigators

  • Study Chair: Zheng Guo, Second Hospital of Shanxi Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2020

Primary Completion (Actual)

June 30, 2023

Study Completion (Estimated)

January 31, 2024

Study Registration Dates

First Submitted

April 15, 2017

First Submitted That Met QC Criteria

April 15, 2017

First Posted (Actual)

April 19, 2017

Study Record Updates

Last Update Posted (Estimated)

January 25, 2024

Last Update Submitted That Met QC Criteria

January 24, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ZGuo

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Hip Replacement

Clinical Trials on total hip replacement

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe